France, Paris, 10.06.2025- 12.06.2025
HIMSS Europe 2025
Workshop: A Holistic Approach to Assessment of AI in Cancer Screening
On behalf of the EUcanScreen project, we are pleased to host a workshop at HIMSS Europe 2025 – one of Europe’s leading conferences on digital health innovation, bringing together healthcare professionals, policymakers, and technology experts from across the continent.
Workshop: A Holistic Approach to Assessment of AI in Cancer Screening
As AI technologies become increasingly embedded in healthcare, it’s crucial to ensure they deliver real value – not just in terms of performance, but also patient benefit, ethical integrity, and system readiness.
In this interactive session, researchers from Denmark, the Netherlands, and Austria will present the Model for ASsessing the value of AI (MAS-AI) – a comprehensive, validated framework developed in collaboration with both experts and patient representatives.
Participants will:
- – Explore the MAS-AI model and its domains including real-world AI cases from cancer screening
- – Take part in a Delphi process to help shape future adaptation of the tool
This session is designed for healthcare decision-makers, researchers, clinicians, and patient partners interested in meaningful and responsible AI evaluation.
When and where:
Date: Tuesday, June 10, 2025
Time: 1:00-3:00 PM
Place: HIMSS Europe 2025, Paris, France
We look forward to seeing you there and working together to shape the future of AI in healthcare.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
